You are here

Biblio

Search

Show only items where

Author

Type

Term

Year

Keyword

Export 14 results:

Author Title [ Type

] Year

Filters: Author is Matsushita, Kunihiro [Clear All Filters]

Journal Article

Hallan SI, Matsushita K, Sang Y, Mahmoodi BK, Black C, Ishani A, Kleefstra N, Naimark D, Roderick P, Tonelli M, et al. Age and association of kidney measures with mortality and end-stage renal disease. JAMA. 2012 ;308(22):2349-60.

Mahmoodi BK, Yatsuya H, Matsushita K, Sang Y, Gottesman RF, Astor BC, Woodward M, Longstreth WT, Psaty BM, Shlipak MG, et al. Association of kidney disease measures with ischemic versus hemorrhagic strokes: pooled analyses of 4 prospective community-based cohorts. Stroke. 2014 ;45(7):1925-31.

Mahmoodi BK, Gansevoort RT, Næss IAnne, Lutsey PL, Brækkan SK, Veeger NJGM, Brodin EE, Meijer K, Sang Y, Matsushita K, et al. Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohorts. Circulation. 2012 ;126(16):1964-71.

Fox CS, Matsushita K, Woodward M, Bilo HJG, Chalmers J, Heerspink HJLambers, Lee BJ, Perkins RM, Rossing P, Sairenchi T, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet. 2012 ;380(9854):1662-73.

Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SHa, Polkinghorne KR, Shankar A, Smith DH, Tonelli M, et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA. 2012 ;307(18):1941-51.

Shlipak MG, Matsushita K, Arnlöv J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, et al. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med. 2013 ;369(10):932-43.

Coresh J, Turin TChowdhury, Matsushita K, Sang Y, Ballew SH, Appel LJ, Arima H, Chadban SJ, Cirillo M, Djurdjev O, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA. 2014 ;311(24):2518-2531.

Khan SS, Matsushita K, Sang Y, Ballew SH, Grams ME, Surapaneni A, Blaha MJ, Carson AP, Chang AR, Ciemins E, et al. Development and Validation of the American Heart Association's PREVENT Equations. Circulation. 2024 ;149(6):430-449.

Robinson-Cohen C, Bartz TM, Lai D, T Ikizler A, Peacock M, Imel EA, Michos ED, Foroud TM, Åkesson K, Taylor KD, et al. Genetic Variants Associated with Circulating Fibroblast Growth Factor 23. J Am Soc Nephrol. 2018 .

Shelbaya K, Arthur V, Yang Y, Dorbala P, Buckley L, Claggett B, Skali H, Dufresne L, Yang T-Y, Engert JC, et al. Large-Scale Proteomics Identifies Novel Biomarkers and Circulating Risk Factors for Aortic Stenosis. J Am Coll Cardiol. 2024 ;83(5):577-591.

Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int. 2011 ;80(1):93-104.

Matsushita K, Ballew SH, Coresh J, Arima H, Arnlöv J, Cirillo M, Ebert N, Hiramoto JS, Kimm H, Shlipak MG, et al. Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 2017 ;5(9):718-728.

Wen CPang, Matsushita K, Coresh J, Iseki K, Islam M, Katz R, McClellan W, Peralta CA, Wang H, de Zeeuw D, et al. Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar. Kidney Int. 2014 ;86(4):819-27.

Lye WKit, Paterson E, Patterson CC, Maxwell AP, Abdul RBanu Binte, Tai SE, Cheng CYu, Kayama T, Yamashita H, Sarnak M, et al. A systematic review and participant-level meta-analysis found little association of retinal microvascular caliber and reduced kidney function. Kidney Int. 2020 .